Crinetics Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $20.55 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $20.55M, a 5.24% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2024 was $19.53M, a 26.35% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2023 was $15.46M, a 41.56% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2022 was $10.92M, a 53.41% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $20.55M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $19.53M 10-K · filed 2026-02-26 | $23.80M 10-K · filed 2025-02-27 |
| 2023-12-31 | $15.46M 10-K · filed 2026-02-26 | $18.18M 10-K · filed 2024-02-28 |
| 2022-12-31 | $10.92M 10-K · filed 2025-02-27 | |
| 2021-12-31 | $7.12M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $2.60M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $2.48M 10-K · filed 2022-03-30 | |
| 2018-12-31 | $1.13M 10-K · filed 2021-03-30 | |
| 2017-12-31 | $525.00K 10-K · filed 2020-03-09 | |
| 2016-12-31 | $342.00K 10-K · filed 2019-03-13 |